SaifM. (2013) “U.S. Food and Drug Administration Approves Paclitaxel Protein-Bound Particles (Abraxane®) in Combination with Gemcitabine as First-Line Treatment of Patients with Metastatic Pancreatic Cancer”, JOP. Journal of the Pancreas, 14(6), pp. 686-688. doi: 10.6092/1590-8577/2028.